YOUNG PETER R 4
4 · CEL SCI CORP · Filed May 17, 2021
Insider Transaction Report
Form 4
CEL SCI CORPCVM
YOUNG PETER R
Director
Transactions
- Award
Options
2021-05-14$0.01/sh+128,000$1,280→ 543,100 totalExercise: $20.61Exp: 2031-05-13→ Common Stock (128,000 underlying)
Footnotes (1)
- [F1]Each option entitles the holder to purchase one share of the Company's common stock at a price of $20.61 per share. The stock options vest 100% upon either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia, or (b) if the closing price of the Company's common stock exceeds $42.00 for one trading day. None of the options will be exercisable before May 13, 2022.